The collaboration with OrientGene and Medomics provides a more comprehensive offering of in vitro diagnostic solutions, tailored to the needs of healthcare professionals in different clinical contexts.
Quilaban has strengthened its offering of Professional Rapid Tests through new strategic partnerships with OrientGene and Medomics, international companies specialising in in vitro diagnostic solutions. This collaboration makes it possible to expand the diversity of tests available and respond to the needs of hospitals, laboratories and other healthcare institutions.
The portfolio covers different clinical areas, including infectious diseases, with tests for respiratory and gastrointestinal infections, fertility and women’s health, detection of drugs of abuse and oncology. Based on immunochromatography technology, these tests are characterised by ease of use and speed in obtaining results, providing relevant information to support clinical decision-making.
The diversity of solutions enables response to different diagnostic needs, providing healthcare professionals with alternatives suited to their daily activity, with a competitive and accessible offering through a national partner with experience in the sector.
In addition to diagnostic equipment, Quilaban now provides an extensive portfolio of rapid tests, complemented by the support of a specialist team and technical and commercial support close to its clients.
The Professional Rapid Tests portfolio can be viewed in the catalogue available online.
